Physician
Carol N. Abalihi, MD, PA
Carol N. Abalihi, MD, PA was paid $972K by Medicaid between Jan 2020 and Dec 2024, across 58 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 24% of everything it billed.
33Billing provider infoCAROL N. ABALIHI, MD, PA
EL PASO, TX 79928
EL PASO, TX 79928
33aNPI1265684856assigned 10/15/2008
33bProvider typePediatrics Physician
28Total paid$972K
24GClaims42,625
24DCodes billed58
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#374 of 1,136
Median peer was paid$329K
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 3,221 | $83K | |
| 2021 | 14,596 | $344K | |
| 2022 | 14,434 | $318K | |
| 2023 | 8,016 | $160K | |
| 2024incomplete | 2,358 | $67K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 6,668 | 4,560 | $237K |
| 99499 | 20% | 2,231 | 2,088 | $196K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 11% | 3,144 | 2,509 | $103K |
| 99050 | 9.3% | 2,559 | 1,406 | $91K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.4% | 3,280 | 2,555 | $82K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8.3% | 1,246 | 1,159 | $80K |
| 99091 | 3.3% | 280 | 138 | $32K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 478 | 369 | $27K |
| 92552 | 2.1% | 1,513 | 1,198 | $20K | |
| 99423 | 1.8% | 450 | 129 | $18K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.5% | 243 | 163 | $15K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.0% | 140 | 127 | $10K |
46 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 479 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 691 | $8K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,339 | $8K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 21 | $7K |
| 99350 | Prolong home eval add 15m | <1% | 117 | $7K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 164 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 415 | $4K |
| 86328 | <1% | 67 | $2K | |
| 81002 | <1% | 1,430 | $2K | |
| 99443 | <1% | 39 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 243 | $1K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 14 | $1K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 14 | $1K |
| 99072 | <1% | 11,634 | $682.70 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 132 | $512.83 |
| 99173 | <1% | 1,646 | $499.84 | |
| 86318 | <1% | 31 | $494.37 | |
| 99000 | <1% | 58 | $450.00 | |
| 90461 | <1% | 109 | $413.61 | |
| 99442 | <1% | 13 | $402.17 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $353.74 |
| 80305 | <1% | 42 | $325.00 | |
| 80053 | Comprehensive metabolic panel | <1% | 53 | $294.42 |
| 80061 | Lipid panel | <1% | 33 | $159.18 |
| 93000 | <1% | 12 | $123.54 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 463 | $99.28 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $71.25 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 13 | $65.28 |
| 81001 | <1% | 51 | $50.92 | |
| 83735 | <1% | 21 | $39.91 | |
| 84100 | <1% | 20 | $16.04 | |
| 96127 | <1% | 21 | $15.06 | |
| 99490 | Ccm add 20min | <1% | 368 | $11.24 |
| 96160 | <1% | 269 | $7.10 | |
| 3725F | 0% | 34 | $0.00 | |
| 3046F | 0% | 17 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 38 | $0.00 |
| 3051F | 0% | 17 | $0.00 | |
| 1159F | 0% | 14 | $0.00 | |
| 3044F | 0% | 31 | $0.00 | |
| 90651 | 0% | 12 | $0.00 | |
| 1126F | 0% | 13 | $0.00 | |
| 90686 | 0% | 91 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 15 | $0.00 |
| 3011F | 0% | 47 | $0.00 | |
| 3052F | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABALIHI, CAROL (MEDICAL DIRECTOR)